Kingsview Wealth Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $363K | Sell |
5,266
-138
| -3% | -$9.53K | 0.01% | 880 |
|
|
2025
Q1 | $375K | Buy |
5,404
+461
| +9% | +$32K | 0.01% | 815 |
|
|
2024
Q4 | $425K | Sell |
4,943
-16,449
| -77% | -$1.41M | 0.01% | 795 |
|
|
2024
Q3 | $2.55M | Sell |
21,392
-3,908
| -15% | -$465K | 0.05% | 313 |
|
|
2024
Q2 | $3.61M | Buy |
25,300
+4,092
| +19% | +$584K | 0.09% | 222 |
|
|
2024
Q1 | $2.72M | Buy |
21,208
+18,942
| +836% | +$2.43M | 0.07% | 262 |
|
|
2023
Q4 | $234K | Sell |
2,266
-378
| -14% | -$39.1K | 0.01% | 846 |
|
|
2023
Q3 | $240K | Buy |
+2,644
| New | +$240K | 0.01% | 830 |
|